EPO Receptor Agonists (Viking Therapeutics)

N/A

Report date: 2025/06/11 10:40:40
NME

Base Information

Drug NameEPO Receptor Agonists (Viking Therapeutics)
Drug Alias NameErythropoietin Receptor Agonists (Ligand)EPO Receptor Agonists (Ligand)LG-5640LG-5460
ClassificationSmall molecules
Mechanisms of ActionErythropoietin receptor agonistsHaematopoiesis stimulants
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLigand Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesViking Therapeutics Inc
Inactive CompaniesLigand Pharmaceuticals Inc
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A